Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of ADVANCED ENZYME TECHNOLOGIES. For more details, see the ADVANCED ENZYME TECHNOLOGIES quarterly results and ADVANCED ENZYME TECHNOLOGIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.5 |
No. of shares | m | 111.82 |
1 Week | % | 8.9 |
1 Month | % | 10.7 |
1 Year | % | 52.6 |
52 week H/L | Rs | 425.1/252.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ADVANCED ENZYME TECHNOLOGIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 263 | 225 | 417 | 503 | 328 | |
Low | Rs | 145 | 91 | 129 | 257 | 225 | |
Sales per share (Unadj.) | Rs | 37.6 | 39.8 | 44.9 | 47.4 | 48.3 | |
Earnings per share (Unadj.) | Rs | 10.4 | 11.9 | 13.5 | 11.1 | 9.3 | |
Diluted earnings per share | Rs | 10.4 | 11.9 | 13.5 | 11.1 | 9.3 | |
Cash flow per share (Unadj.) | Rs | 12.3 | 14.2 | 16.1 | 14.2 | 12.4 | |
Dividends per share (Unadj.) | Rs | 0.60 | 0.60 | 0.90 | 1.00 | 5.00 | |
Adj. dividends per share | Rs | 0.60 | 0.60 | 0.90 | 1.00 | 5.00 | |
Avg Dividend yield | % | 0.3 | 0.4 | 0.3 | 0.3 | 1.8 | |
Book value per share (Unadj.) | Rs | 60.5 | 74.9 | 86.7 | 97.4 | 110.5 | |
Adj. book value per share | Rs | 60.4 | 74.8 | 86.6 | 97.3 | 110.4 | |
Shares outstanding (eoy) | m | 111.65 | 111.68 | 111.73 | 111.73 | 111.82 | |
Price / Sales ratio | x | 5.4 | 4.0 | 6.1 | 8.0 | 5.7 | |
Avg P/E ratio | x | 19.7 | 13.3 | 20.2 | 34.3 | 29.8 | |
P/CF ratio (eoy) | x | 16.7 | 11.1 | 16.9 | 26.7 | 22.3 | |
Price / Book Value ratio | x | 3.4 | 2.1 | 3.1 | 3.9 | 2.5 | |
Dividend payout | % | 5.8 | 5.0 | 6.6 | 9.0 | 53.8 | |
Avg Mkt Cap | Rs m | 22,818 | 17,648 | 30,491 | 42,457 | 30,939 | |
Total wages/salary | Rs m | 780 | 802 | 871 | 1,040 | 1,148 |
ADVANCED ENZYME TECHNOLOGIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,196 | 4,440 | 5,018 | 5,294 | 5,406 | |
Other income | Rs m | 57 | 59 | 88 | 64 | 255 | |
Total revenues | Rs m | 4,253 | 4,499 | 5,107 | 5,358 | 5,661 | |
Gross profit | Rs m | 1,826 | 2,031 | 2,326 | 2,026 | 1,534 | |
Depreciation | Rs m | 211 | 258 | 287 | 350 | 350 | |
Interest | Rs m | 52 | 41 | 26 | 30 | 35 | |
Profit before tax | Rs m | 1,620 | 1,792 | 2,101 | 1,711 | 1,404 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 461 | 461 | 588 | 473 | 365 | |
Profit after tax | Rs m | 1,159 | 1,330 | 1,513 | 1,238 | 1,039 | |
Gross profit margin | % | 43.5 | 45.8 | 46.3 | 38.3 | 28.4 | |
Effective tax rate | % | 28.4 | 25.7 | 28.0 | 27.6 | 26.0 | |
Net profit margin | % | 27.6 | 30.0 | 30.1 | 23.4 | 19.2 |
ADVANCED ENZYME TECHNOLOGIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,821 | 3,756 | 5,160 | 6,044 | 7,221 | |
Current liabilities | Rs m | 651 | 595 | 676 | 604 | 776 | |
Net working cap to sales | % | 51.7 | 71.2 | 89.4 | 102.8 | 119.2 | |
Current ratio | x | 4.3 | 6.3 | 7.6 | 10.0 | 9.3 | |
Inventory Days | Days | 107 | 116 | 102 | 85 | 255 | |
Debtors Days | Days | 51 | 61 | 63 | 61 | 68 | |
Net fixed assets | Rs m | 5,183 | 5,908 | 6,333 | 6,558 | 6,884 | |
Share capital | Rs m | 223 | 223 | 223 | 224 | 224 | |
"Free" reserves | Rs m | 6,530 | 8,137 | 9,460 | 10,656 | 12,127 | |
Net worth | Rs m | 6,753 | 8,360 | 9,683 | 10,880 | 12,351 | |
Long term debt | Rs m | 70 | 42 | 99 | 81 | 78 | |
Total assets | Rs m | 8,052 | 9,712 | 11,493 | 12,602 | 14,105 | |
Interest coverage | x | 32.1 | 44.9 | 82.8 | 58.9 | 41.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | |
Return on assets | % | 15.0 | 14.1 | 13.4 | 10.1 | 7.6 | |
Return on equity | % | 17.2 | 15.9 | 15.6 | 11.4 | 8.4 | |
Return on capital | % | 24.5 | 21.8 | 21.7 | 15.9 | 11.6 | |
Exports to sales | % | 15.9 | 16.4 | 12.9 | 13.9 | 17.3 | |
Imports to sales | % | 6.8 | 6.1 | 5.9 | 8.2 | 7.8 | |
Exports (fob) | Rs m | 669 | 729 | 648 | 736 | 937 | |
Imports (cif) | Rs m | 286 | 269 | 298 | 435 | 420 | |
Fx inflow | Rs m | 669 | 729 | 648 | 736 | 937 | |
Fx outflow | Rs m | 286 | 269 | 298 | 435 | 420 | |
Net fx | Rs m | 383 | 459 | 351 | 301 | 518 |
ADVANCED ENZYME TECHNOLOGIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,286 | 1,409 | 1,630 | 1,223 | 1,404 | |
From Investments | Rs m | -1,247 | -445 | -260 | -38 | -2,982 | |
From Financial Activity | Rs m | -431 | -386 | -264 | -485 | -258 | |
Net Cashflow | Rs m | -381 | 596 | 1,093 | 754 | -1,709 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Vasant Rathi | COMP SEC: Sanjay Basantani | YEAR OF INC: 1989 | BSE CODE: 540025 | FV (Rs): 2 | DIV YIELD (%): 1.3 |
Read: ADVANCED ENZYME TECHNOLOGIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ADVANCED ENZYME TECHNOLOGIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.